Blocking NGF and its receptors, or the involved pathways, alongside chemotherapy could sensitize cancer cells to chemotherapy, preventing the development of drug resistance and possibly helping overcome or delay the emergence of drug resistance by targeting multiple pathways simultaneously [262,263]. The gene discussed is NGF; the disease is cancer.